Oxcarbazepine Market, Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 27-Feb-2022
No. of pages: 127

Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. The presence of an extra oxygen atom in the structure reduces the susceptibility of the drug to hepatic metabolism, leading to prolonged pharmacological action or half life of the drug. 

This report contains market size and forecasts of Oxcarbazepine in global, including the following market information:

Global Oxcarbazepine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Oxcarbazepine Market Sales, 2017-2022, 2023-2028, (M Unit)

Global top five Oxcarbazepine companies in 2021 (%)

The global Oxcarbazepine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets (150mg, 300mg, 600mg) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oxcarbazepine include Novartis (Trileptal), Supernus Pharmaceuticals (Oxtellar XR), Sun Pharm, Ranbaxy Pharmaceuticals, Jubilant Generics, Taro Pharmaceuticals, Mylan, Stada Group and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxcarbazepine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oxcarbazepine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Unit)

Global Oxcarbazepine Market Segment Percentages, by Type, 2021 (%)

- Tablets (150mg, 300mg, 600mg)

- Oral Suspension

Global Oxcarbazepine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Unit)

Global Oxcarbazepine Market Segment Percentages, by Application, 2021 (%)

- Pediatric Use (Aged 2-4 years, 4-16 years)

- Adult Use

Global Oxcarbazepine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Unit)

Global Oxcarbazepine Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oxcarbazepine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Oxcarbazepine revenues share in global market, 2021 (%)

Key companies Oxcarbazepine sales in global market, 2017-2022 (Estimated), (M Unit)

Key companies Oxcarbazepine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Novartis (Trileptal)

- Supernus Pharmaceuticals (Oxtellar XR)

- Sun Pharm

- Ranbaxy Pharmaceuticals

- Jubilant Generics

- Taro Pharmaceuticals

- Mylan

- Stada Group

- Glenmark Pharmaceuticals

- ANI Pharmaceuticals

- Teva Pharmaceutical

- Roxane Laboratories

- Nobelpharma

- Apotex

- Nexgen pharma

- Amneal Pharmaceuticals

- Hikma Pharmaceuticals

- Jamp Pharma

- Neuraxpharm

- Orion Corporation

- Sihuan Pharm

- Humanwell Healthcare

- Huikang Pharmaceutical

Oxcarbazepine Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Oxcarbazepine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oxcarbazepine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oxcarbazepine Overall Market Size
2.1 Global Oxcarbazepine Market Size: 2021 VS 2028
2.2 Global Oxcarbazepine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oxcarbazepine Sales: 2017-2028
3 Company Landscape
3.1 Top Oxcarbazepine Players in Global Market
3.2 Top Global Oxcarbazepine Companies Ranked by Revenue
3.3 Global Oxcarbazepine Revenue by Companies
3.4 Global Oxcarbazepine Sales by Companies
3.5 Global Oxcarbazepine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oxcarbazepine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oxcarbazepine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oxcarbazepine Players in Global Market
3.8.1 List of Global Tier 1 Oxcarbazepine Companies
3.8.2 List of Global Tier 2 and Tier 3 Oxcarbazepine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oxcarbazepine Market Size Markets, 2021 & 2028
4.1.2 Tablets (150mg, 300mg, 600mg)
4.1.3 Oral Suspension
4.2 By Type - Global Oxcarbazepine Revenue & Forecasts
4.2.1 By Type - Global Oxcarbazepine Revenue, 2017-2022
4.2.2 By Type - Global Oxcarbazepine Revenue, 2023-2028
4.2.3 By Type - Global Oxcarbazepine Revenue Market Share, 2017-2028
4.3 By Type - Global Oxcarbazepine Sales & Forecasts
4.3.1 By Type - Global Oxcarbazepine Sales, 2017-2022
4.3.2 By Type - Global Oxcarbazepine Sales, 2023-2028
4.3.3 By Type - Global Oxcarbazepine Sales Market Share, 2017-2028
4.4 By Type - Global Oxcarbazepine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Oxcarbazepine Market Size, 2021 & 2028
5.1.2 Pediatric Use (Aged 2-4 years, 4-16 years)
5.1.3 Adult Use
5.2 By Application - Global Oxcarbazepine Revenue & Forecasts
5.2.1 By Application - Global Oxcarbazepine Revenue, 2017-2022
5.2.2 By Application - Global Oxcarbazepine Revenue, 2023-2028
5.2.3 By Application - Global Oxcarbazepine Revenue Market Share, 2017-2028
5.3 By Application - Global Oxcarbazepine Sales & Forecasts
5.3.1 By Application - Global Oxcarbazepine Sales, 2017-2022
5.3.2 By Application - Global Oxcarbazepine Sales, 2023-2028
5.3.3 By Application - Global Oxcarbazepine Sales Market Share, 2017-2028
5.4 By Application - Global Oxcarbazepine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Oxcarbazepine Market Size, 2021 & 2028
6.2 By Region - Global Oxcarbazepine Revenue & Forecasts
6.2.1 By Region - Global Oxcarbazepine Revenue, 2017-2022
6.2.2 By Region - Global Oxcarbazepine Revenue, 2023-2028
6.2.3 By Region - Global Oxcarbazepine Revenue Market Share, 2017-2028
6.3 By Region - Global Oxcarbazepine Sales & Forecasts
6.3.1 By Region - Global Oxcarbazepine Sales, 2017-2022
6.3.2 By Region - Global Oxcarbazepine Sales, 2023-2028
6.3.3 By Region - Global Oxcarbazepine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Oxcarbazepine Revenue, 2017-2028
6.4.2 By Country - North America Oxcarbazepine Sales, 2017-2028
6.4.3 US Oxcarbazepine Market Size, 2017-2028
6.4.4 Canada Oxcarbazepine Market Size, 2017-2028
6.4.5 Mexico Oxcarbazepine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Oxcarbazepine Revenue, 2017-2028
6.5.2 By Country - Europe Oxcarbazepine Sales, 2017-2028
6.5.3 Germany Oxcarbazepine Market Size, 2017-2028
6.5.4 France Oxcarbazepine Market Size, 2017-2028
6.5.5 U.K. Oxcarbazepine Market Size, 2017-2028
6.5.6 Italy Oxcarbazepine Market Size, 2017-2028
6.5.7 Russia Oxcarbazepine Market Size, 2017-2028
6.5.8 Nordic Countries Oxcarbazepine Market Size, 2017-2028
6.5.9 Benelux Oxcarbazepine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Oxcarbazepine Revenue, 2017-2028
6.6.2 By Region - Asia Oxcarbazepine Sales, 2017-2028
6.6.3 China Oxcarbazepine Market Size, 2017-2028
6.6.4 Japan Oxcarbazepine Market Size, 2017-2028
6.6.5 South Korea Oxcarbazepine Market Size, 2017-2028
6.6.6 Southeast Asia Oxcarbazepine Market Size, 2017-2028
6.6.7 India Oxcarbazepine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Oxcarbazepine Revenue, 2017-2028
6.7.2 By Country - South America Oxcarbazepine Sales, 2017-2028
6.7.3 Brazil Oxcarbazepine Market Size, 2017-2028
6.7.4 Argentina Oxcarbazepine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oxcarbazepine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Oxcarbazepine Sales, 2017-2028
6.8.3 Turkey Oxcarbazepine Market Size, 2017-2028
6.8.4 Israel Oxcarbazepine Market Size, 2017-2028
6.8.5 Saudi Arabia Oxcarbazepine Market Size, 2017-2028
6.8.6 UAE Oxcarbazepine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis (Trileptal)
7.1.1 Novartis (Trileptal) Corporate Summary
7.1.2 Novartis (Trileptal) Business Overview
7.1.3 Novartis (Trileptal) Oxcarbazepine Major Product Offerings
7.1.4 Novartis (Trileptal) Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.1.5 Novartis (Trileptal) Key News
7.2 Supernus Pharmaceuticals (Oxtellar XR)
7.2.1 Supernus Pharmaceuticals (Oxtellar XR) Corporate Summary
7.2.2 Supernus Pharmaceuticals (Oxtellar XR) Business Overview
7.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Major Product Offerings
7.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.2.5 Supernus Pharmaceuticals (Oxtellar XR) Key News
7.3 Sun Pharm
7.3.1 Sun Pharm Corporate Summary
7.3.2 Sun Pharm Business Overview
7.3.3 Sun Pharm Oxcarbazepine Major Product Offerings
7.3.4 Sun Pharm Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.3.5 Sun Pharm Key News
7.4 Ranbaxy Pharmaceuticals
7.4.1 Ranbaxy Pharmaceuticals Corporate Summary
7.4.2 Ranbaxy Pharmaceuticals Business Overview
7.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Major Product Offerings
7.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.4.5 Ranbaxy Pharmaceuticals Key News
7.5 Jubilant Generics
7.5.1 Jubilant Generics Corporate Summary
7.5.2 Jubilant Generics Business Overview
7.5.3 Jubilant Generics Oxcarbazepine Major Product Offerings
7.5.4 Jubilant Generics Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.5.5 Jubilant Generics Key News
7.6 Taro Pharmaceuticals
7.6.1 Taro Pharmaceuticals Corporate Summary
7.6.2 Taro Pharmaceuticals Business Overview
7.6.3 Taro Pharmaceuticals Oxcarbazepine Major Product Offerings
7.6.4 Taro Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.6.5 Taro Pharmaceuticals Key News
7.7 Mylan
7.7.1 Mylan Corporate Summary
7.7.2 Mylan Business Overview
7.7.3 Mylan Oxcarbazepine Major Product Offerings
7.7.4 Mylan Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.7.5 Mylan Key News
7.8 Stada Group
7.8.1 Stada Group Corporate Summary
7.8.2 Stada Group Business Overview
7.8.3 Stada Group Oxcarbazepine Major Product Offerings
7.8.4 Stada Group Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.8.5 Stada Group Key News
7.9 Glenmark Pharmaceuticals
7.9.1 Glenmark Pharmaceuticals Corporate Summary
7.9.2 Glenmark Pharmaceuticals Business Overview
7.9.3 Glenmark Pharmaceuticals Oxcarbazepine Major Product Offerings
7.9.4 Glenmark Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.9.5 Glenmark Pharmaceuticals Key News
7.10 ANI Pharmaceuticals
7.10.1 ANI Pharmaceuticals Corporate Summary
7.10.2 ANI Pharmaceuticals Business Overview
7.10.3 ANI Pharmaceuticals Oxcarbazepine Major Product Offerings
7.10.4 ANI Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.10.5 ANI Pharmaceuticals Key News
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Corporate Summary
7.11.2 Teva Pharmaceutical Oxcarbazepine Business Overview
7.11.3 Teva Pharmaceutical Oxcarbazepine Major Product Offerings
7.11.4 Teva Pharmaceutical Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.11.5 Teva Pharmaceutical Key News
7.12 Roxane Laboratories
7.12.1 Roxane Laboratories Corporate Summary
7.12.2 Roxane Laboratories Oxcarbazepine Business Overview
7.12.3 Roxane Laboratories Oxcarbazepine Major Product Offerings
7.12.4 Roxane Laboratories Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.12.5 Roxane Laboratories Key News
7.13 Nobelpharma
7.13.1 Nobelpharma Corporate Summary
7.13.2 Nobelpharma Oxcarbazepine Business Overview
7.13.3 Nobelpharma Oxcarbazepine Major Product Offerings
7.13.4 Nobelpharma Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.13.5 Nobelpharma Key News
7.14 Apotex
7.14.1 Apotex Corporate Summary
7.14.2 Apotex Business Overview
7.14.3 Apotex Oxcarbazepine Major Product Offerings
7.14.4 Apotex Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.14.5 Apotex Key News
7.15 Nexgen pharma
7.15.1 Nexgen pharma Corporate Summary
7.15.2 Nexgen pharma Business Overview
7.15.3 Nexgen pharma Oxcarbazepine Major Product Offerings
7.15.4 Nexgen pharma Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.15.5 Nexgen pharma Key News
7.16 Amneal Pharmaceuticals
7.16.1 Amneal Pharmaceuticals Corporate Summary
7.16.2 Amneal Pharmaceuticals Business Overview
7.16.3 Amneal Pharmaceuticals Oxcarbazepine Major Product Offerings
7.16.4 Amneal Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.16.5 Amneal Pharmaceuticals Key News
7.17 Hikma Pharmaceuticals
7.17.1 Hikma Pharmaceuticals Corporate Summary
7.17.2 Hikma Pharmaceuticals Business Overview
7.17.3 Hikma Pharmaceuticals Oxcarbazepine Major Product Offerings
7.17.4 Hikma Pharmaceuticals Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.17.5 Hikma Pharmaceuticals Key News
7.18 Jamp Pharma
7.18.1 Jamp Pharma Corporate Summary
7.18.2 Jamp Pharma Business Overview
7.18.3 Jamp Pharma Oxcarbazepine Major Product Offerings
7.18.4 Jamp Pharma Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.18.5 Jamp Pharma Key News
7.19 Neuraxpharm
7.19.1 Neuraxpharm Corporate Summary
7.19.2 Neuraxpharm Business Overview
7.19.3 Neuraxpharm Oxcarbazepine Major Product Offerings
7.19.4 Neuraxpharm Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.19.5 Neuraxpharm Key News
7.20 Orion Corporation
7.20.1 Orion Corporation Corporate Summary
7.20.2 Orion Corporation Business Overview
7.20.3 Orion Corporation Oxcarbazepine Major Product Offerings
7.20.4 Orion Corporation Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.20.5 Orion Corporation Key News
7.21 Sihuan Pharm
7.21.1 Sihuan Pharm Corporate Summary
7.21.2 Sihuan Pharm Business Overview
7.21.3 Sihuan Pharm Oxcarbazepine Major Product Offerings
7.21.4 Sihuan Pharm Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.21.5 Sihuan Pharm Key News
7.22 Humanwell Healthcare
7.22.1 Humanwell Healthcare Corporate Summary
7.22.2 Humanwell Healthcare Business Overview
7.22.3 Humanwell Healthcare Oxcarbazepine Major Product Offerings
7.22.4 Humanwell Healthcare Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.22.5 Humanwell Healthcare Key News
7.23 Huikang Pharmaceutical
7.23.1 Huikang Pharmaceutical Corporate Summary
7.23.2 Huikang Pharmaceutical Business Overview
7.23.3 Huikang Pharmaceutical Oxcarbazepine Major Product Offerings
7.23.4 Huikang Pharmaceutical Oxcarbazepine Sales and Revenue in Global (2017-2022)
7.23.5 Huikang Pharmaceutical Key News
8 Global Oxcarbazepine Production Capacity, Analysis
8.1 Global Oxcarbazepine Production Capacity, 2017-2028
8.2 Oxcarbazepine Production Capacity of Key Manufacturers in Global Market
8.3 Global Oxcarbazepine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oxcarbazepine Supply Chain Analysis
10.1 Oxcarbazepine Industry Value Chain
10.2 Oxcarbazepine Upstream Market
10.3 Oxcarbazepine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oxcarbazepine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oxcarbazepine in Global Market
Table 2. Top Oxcarbazepine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Oxcarbazepine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Oxcarbazepine Revenue Share by Companies, 2017-2022
Table 5. Global Oxcarbazepine Sales by Companies, (M Unit), 2017-2022
Table 6. Global Oxcarbazepine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Oxcarbazepine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Oxcarbazepine Product Type
Table 9. List of Global Tier 1 Oxcarbazepine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oxcarbazepine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Oxcarbazepine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Oxcarbazepine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Oxcarbazepine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Oxcarbazepine Sales (M Unit), 2017-2022
Table 15. By Type - Global Oxcarbazepine Sales (M Unit), 2023-2028
Table 16. By Application - Global Oxcarbazepine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Oxcarbazepine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Oxcarbazepine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Oxcarbazepine Sales (M Unit), 2017-2022
Table 20. By Application - Global Oxcarbazepine Sales (M Unit), 2023-2028
Table 21. By Region - Global Oxcarbazepine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Oxcarbazepine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Oxcarbazepine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Oxcarbazepine Sales (M Unit), 2017-2022
Table 25. By Region - Global Oxcarbazepine Sales (M Unit), 2023-2028
Table 26. By Country - North America Oxcarbazepine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Oxcarbazepine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Oxcarbazepine Sales, (M Unit), 2017-2022
Table 29. By Country - North America Oxcarbazepine Sales, (M Unit), 2023-2028
Table 30. By Country - Europe Oxcarbazepine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Oxcarbazepine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Oxcarbazepine Sales, (M Unit), 2017-2022
Table 33. By Country - Europe Oxcarbazepine Sales, (M Unit), 2023-2028
Table 34. By Region - Asia Oxcarbazepine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Oxcarbazepine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Oxcarbazepine Sales, (M Unit), 2017-2022
Table 37. By Region - Asia Oxcarbazepine Sales, (M Unit), 2023-2028
Table 38. By Country - South America Oxcarbazepine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Oxcarbazepine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Oxcarbazepine Sales, (M Unit), 2017-2022
Table 41. By Country - South America Oxcarbazepine Sales, (M Unit), 2023-2028
Table 42. By Country - Middle East & Africa Oxcarbazepine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Oxcarbazepine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Oxcarbazepine Sales, (M Unit), 2017-2022
Table 45. By Country - Middle East & Africa Oxcarbazepine Sales, (M Unit), 2023-2028
Table 46. Novartis (Trileptal) Corporate Summary
Table 47. Novartis (Trileptal) Oxcarbazepine Product Offerings
Table 48. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Supernus Pharmaceuticals (Oxtellar XR) Corporate Summary
Table 50. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Offerings
Table 51. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sun Pharm Corporate Summary
Table 53. Sun Pharm Oxcarbazepine Product Offerings
Table 54. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Ranbaxy Pharmaceuticals Corporate Summary
Table 56. Ranbaxy Pharmaceuticals Oxcarbazepine Product Offerings
Table 57. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Jubilant Generics Corporate Summary
Table 59. Jubilant Generics Oxcarbazepine Product Offerings
Table 60. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Taro Pharmaceuticals Corporate Summary
Table 62. Taro Pharmaceuticals Oxcarbazepine Product Offerings
Table 63. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Mylan Corporate Summary
Table 65. Mylan Oxcarbazepine Product Offerings
Table 66. Mylan Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Stada Group Corporate Summary
Table 68. Stada Group Oxcarbazepine Product Offerings
Table 69. Stada Group Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Glenmark Pharmaceuticals Corporate Summary
Table 71. Glenmark Pharmaceuticals Oxcarbazepine Product Offerings
Table 72. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. ANI Pharmaceuticals Corporate Summary
Table 74. ANI Pharmaceuticals Oxcarbazepine Product Offerings
Table 75. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Teva Pharmaceutical Corporate Summary
Table 77. Teva Pharmaceutical Oxcarbazepine Product Offerings
Table 78. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Roxane Laboratories Corporate Summary
Table 80. Roxane Laboratories Oxcarbazepine Product Offerings
Table 81. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Nobelpharma Corporate Summary
Table 83. Nobelpharma Oxcarbazepine Product Offerings
Table 84. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Apotex Corporate Summary
Table 86. Apotex Oxcarbazepine Product Offerings
Table 87. Apotex Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Nexgen pharma Corporate Summary
Table 89. Nexgen pharma Oxcarbazepine Product Offerings
Table 90. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Amneal Pharmaceuticals Corporate Summary
Table 92. Amneal Pharmaceuticals Oxcarbazepine Product Offerings
Table 93. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Hikma Pharmaceuticals Corporate Summary
Table 95. Hikma Pharmaceuticals Oxcarbazepine Product Offerings
Table 96. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Jamp Pharma Corporate Summary
Table 98. Jamp Pharma Oxcarbazepine Product Offerings
Table 99. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Neuraxpharm Corporate Summary
Table 101. Neuraxpharm Oxcarbazepine Product Offerings
Table 102. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Orion Corporation Corporate Summary
Table 104. Orion Corporation Oxcarbazepine Product Offerings
Table 105. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Sihuan Pharm Corporate Summary
Table 107. Sihuan Pharm Oxcarbazepine Product Offerings
Table 108. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Humanwell Healthcare Corporate Summary
Table 110. Humanwell Healthcare Oxcarbazepine Product Offerings
Table 111. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Huikang Pharmaceutical Corporate Summary
Table 113. Huikang Pharmaceutical Oxcarbazepine Product Offerings
Table 114. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Oxcarbazepine Production Capacity (M Unit) of Key Manufacturers in Global Market, 2020-2022 (M Unit)
Table 116. Global Oxcarbazepine Capacity Market Share of Key Manufacturers, 2020-2022
Table 117. Global Oxcarbazepine Production by Region, 2017-2022 (M Unit)
Table 118. Global Oxcarbazepine Production by Region, 2023-2028 (M Unit)
Table 119. Oxcarbazepine Market Opportunities & Trends in Global Market
Table 120. Oxcarbazepine Market Drivers in Global Market
Table 121. Oxcarbazepine Market Restraints in Global Market
Table 122. Oxcarbazepine Raw Materials
Table 123. Oxcarbazepine Raw Materials Suppliers in Global Market
Table 124. Typical Oxcarbazepine Downstream
Table 125. Oxcarbazepine Downstream Clients in Global Market
Table 126. Oxcarbazepine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oxcarbazepine Segment by Type
Figure 2. Oxcarbazepine Segment by Application
Figure 3. Global Oxcarbazepine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oxcarbazepine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oxcarbazepine Revenue, 2017-2028 (US$, Mn)
Figure 7. Oxcarbazepine Sales in Global Market: 2017-2028 (M Unit)
Figure 8. The Top 3 and 5 Players Market Share by Oxcarbazepine Revenue in 2021
Figure 9. By Type - Global Oxcarbazepine Sales Market Share, 2017-2028
Figure 10. By Type - Global Oxcarbazepine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Oxcarbazepine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Oxcarbazepine Sales Market Share, 2017-2028
Figure 13. By Application - Global Oxcarbazepine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Oxcarbazepine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Oxcarbazepine Sales Market Share, 2017-2028
Figure 16. By Region - Global Oxcarbazepine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Oxcarbazepine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Oxcarbazepine Sales Market Share, 2017-2028
Figure 19. US Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Oxcarbazepine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Oxcarbazepine Sales Market Share, 2017-2028
Figure 24. Germany Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 25. France Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Oxcarbazepine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Oxcarbazepine Sales Market Share, 2017-2028
Figure 33. China Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 37. India Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Oxcarbazepine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Oxcarbazepine Sales Market Share, 2017-2028
Figure 40. Brazil Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Oxcarbazepine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Oxcarbazepine Sales Market Share, 2017-2028
Figure 44. Turkey Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Oxcarbazepine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Oxcarbazepine Production Capacity (M Unit), 2017-2028
Figure 49. The Percentage of Production Oxcarbazepine by Region, 2021 VS 2028
Figure 50. Oxcarbazepine Industry Value Chain
Figure 51. Marketing Channels
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs